This article is more than 5 years old. Information may no longer be current.

FDA approves Alcon's AcrySof IQ aspheric IOL with UltraSert preloaded delivery system

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Alcon received FDA approval for its AcrySof IQ aspheric IOL with the UltraSert preloaded delivery system for cataract surgery, according to a Novartis press release.

The delivery system combines a manually loaded device with a disposable preloaded injector.

It features the TensionGlide plunger for controlled delivery of the IOL into the capsular bag, a tip designed to support consistent IOL folding and placement, a smaller nozzle tip for a corneal incision down to 2.2 mm to insert the IOL, and a Depth Guard nozzle to prevent the device from being inserted deeper than necessary, the release said.

“We are addressing a distinct need of cataract surgeons for a single-use system that maximizes their control during surgery and helps them streamline procedures to enable improved patient outcomes,” Sergio Duplan, Alcon region president, U.S. and Canada, said in the release.

The UltraSert system received CE mark approval in June, the release said.